|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.80 SEK | +0.54% |
|
+3.05% | -5.34% |
| 20/07 | Danske Bank raises Cellavision target price to 187 kronor (180), reiterates buy - BN | FW |
| 20/07 | DNB Carnegie raises price target for Cellavision to 180 kronor (175), reiterates buy | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,549 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | -5.34% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,362 | 3,327 | 3,271 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | -6.28% | -1.02% | -1.7% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 25.5x | 20.3x | 17.9x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 3.67x | 3.33x | 2.99x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -2.78x | 0.8x | 1.3x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 4.58x | 4.08x | 3.76x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 4.34x | 3.82x | 3.46x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 14.8x | 12x | 10.6x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 18.9x | 14.9x | 12.9x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 31.2x | 29.6x | 23.4x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 3.21% | 3.37% | 4.27% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.133 | 3.4 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.85% | 2.11% | 2.28% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.831 | 7.313 | 8.294 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.2% | 42.8% | 41% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 775.1 | 870 | 944.7 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.3 | 277.7 | 309.5 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 177.5 | 222.9 | 253.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 139 | 174.4 | 197.7 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -187.5 | -221.9 | -278.4 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 148.80 | 148.80 | 148.80 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.38x | 4.31x | 14.7x | 1.86% | 37Cr | |
| 60.3x | 4.74x | 15.9x | 0.35% | 1.62TCr | |
| 42.95x | - | - | 1.88% | 184.63Cr | |
| -11.07x | 1.32x | 5.81x | -.--% | 120.77Cr | |
| 16.23x | 2.29x | 7.67x | 1.44% | 97Cr | |
| 52.79x | - | - | 0.85% | 54Cr | |
| 51.27x | - | - | - | 50Cr | |
| 18.87x | 2.66x | 11.38x | 1.81% | 39Cr | |
| -13.88x | - | - | - | 35Cr | |
| Average | 26.98x | 3.07x | 11.09x | 1.17% | 248.89Cr | |
| Weighted average by Cap. | 50.29x | 4.35x | 14.74x | 0.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
